KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Johnson & Johnson (JNJ) R&D In Process (2016 - 2023)

Johnson & Johnson's R&D In Process history spans 13 years, with the latest figure at $49.0 million for Q2 2023.

  • On a quarterly basis, R&D In Process fell 91.97% to $49.0 million in Q2 2023 year-over-year; TTM through Apr 2023 was $222.0 million, a 85.3% decrease, with the full-year FY2023 number at $783.0 million, down 13.0% from a year prior.
  • R&D In Process hit $49.0 million in Q2 2023 for Johnson & Johnson, down from $173.0 million in the prior quarter.
  • Over the last five years, R&D In Process for JNJ hit a ceiling of $900.0 million in Q4 2021 and a floor of $6.0 million in Q2 2020.
  • Historically, R&D In Process has averaged $350.4 million across 5 years, with a median of $155.5 million in 2020.
  • Biggest five-year swings in R&D In Process: surged 552.17% in 2021 and later tumbled 91.97% in 2023.
  • Tracing JNJ's R&D In Process over 5 years: stood at $890.0 million in 2019, then tumbled by 84.49% to $138.0 million in 2020, then surged by 552.17% to $900.0 million in 2021, then tumbled by 32.22% to $610.0 million in 2022, then crashed by 91.97% to $49.0 million in 2023.
  • Business Quant data shows R&D In Process for JNJ at $49.0 million in Q2 2023, $173.0 million in Q1 2023, and $610.0 million in Q2 2022.